Price History:-52.14%(TTM)
Over the latest trailing 12-month period, price cagr is -52.14%. The comparable SPY value is +20.86%. Year-to-date price return is -47.38%. Price CAGR uses adjusted close price history and excludes dividends.
Current Price
$148.88
+$4.98 (+3.46%)
Previous Close: $143.90
Last Session
- Open
- $144.83
- Day High
- $149.63
- Day Low
- $144.82
- Volume
- 1.39M
- Avg Volume
- 1.54M
52-Week Position
5%
of the 52-week price range
- From 52-week high
- -58.05%
- From 52-week low
- +7.27%
52-Week Price Range
52-Week Low
$138.79
Jun 22, 2026
Current Price
$148.88
5% of range
52-Week High
$354.88
Sep 9, 2025
Price Returns by Period
1 Day
+3.46%
7 Days
+2.14%
30 Days
-3.20%
YTD
-47.38%
1 Year
-51.38%
vs 52W High
-58.05%
PODD Price Chart
Long-Term Performance (CAGR)
Price CAGR (3Y)
-19.71%
Price CAGR (5Y)
-11.68%
Total Return CAGR (3Y)
-19.71%
Total Return CAGR (5Y)
-11.68%
CAGR (Compound Annual Growth Rate) shows the annualized return over the specified period. Total Return includes dividends reinvested.
Key Price Statistics
| Current Price | $148.88 |
| Previous Close | $143.90 |
| Day Range | $144.82 - $149.63 |
| 52-Week Range | $138.79 - $354.88 |
| Volume | 1.39M |
| Average Volume | 1.54M |
| Market Cap | $10.31B |
| % from 52W High | -58.05% |
Related Metrics
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ashley A. McEvoy